SCHEMBL5587009

SCHEMBL5587009

Cc1c(F)cc(OC(=O)O)c(O)c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
POLA1 P09884 1/20 0.36
ANTXR2 P58335 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
PTGS2 P35354 1/20 0.34
CYP3A4 P08684 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA3 P07451 1/20 0.32
PKM P14618 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590149 0.81 CYP3A4 (0.41) POLBPOLA1ANTXR2PTGS2CYP3A4
SCHEMBL5589472 0.78 LCK (0.38) POLBPOLA1ANTXR2PTGS2CYP3A4
SCHEMBL5589383 0.78 TTR (0.35) POLBPOLA1ANTXR2PTGS2CYP3A4
SCHEMBL5589361 0.78 CYP3A4 (0.33) POLBPOLA1ANTXR2PTGS2CYP3A4
SCHEMBL5588963 0.77 POLB (0.42) POLBPOLA1ANTXR2PTGS2LMNA
SCHEMBL5676826 0.76 FASN (0.33) POLBPOLA1ANTXR2CYP3A4CA12
SCHEMBL15454206 0.76 CES2 (0.34) POLBPOLA1ANTXR2HDAC1HDAC6
SCHEMBL21757370 0.76 HDAC1 (0.40) POLBHDAC1HDAC6PTGS2LMNA
SCHEMBL5588734 0.74 POLB (0.33) POLBPOLA1ANTXR2PTGS2LMNA
SCHEMBL5587475 0.74 ALOX5 (0.43) MAPK1HTTRAB9APKMALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 POLB 1104/4885POLA1 784/4885ANTXR2 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.